Initially, in relation to GRN genetic mutation, it appears that individuals with bvFTD carrying GRN mutations demonstrate a faster rate of whole brain atrophy, suggesting a more rapid disease progression, compared to patients carrying other genetic variations, such as MAPT [46,47]. This evidence concerns the gene MAPT and Brain atrophy.